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Regulation of IFN signaling is critical in host recognition and response
to pathogens while its dysregulation underlies the pathogenesis of
several chronic diseases. STimulator of IFN Genes (STING) has been
identified as a critical mediator of IFN inducing innate immune
pathways, but little is known about direct coregulators of this
protein. We report here that TMEM203, a conserved putative trans-
membrane protein, is an intracellular regulator of STING-mediated
signaling. We show that TMEM203 interacts, functionally cooperates,
and comigrates with STING following cell stimulation, which in turn
leads to the activation of the kinase TBK1, and the IRF3 transcription
factor. This induces target genes in macrophages, including IFN-β.
Using Tmem203 knockout bone marrow-derived macrophages and
transient knockdown of TMEM203 in human monocyte-derived mac-
rophages, we show that TMEM203 protein is required for cGAMP-
induced STING activation. Unlike STING, TMEM203 mRNA levels are
elevated in T cells from patients with systemic lupus erythematosus,
a disease characterized by the overexpression of type I interferons.
Moreover, TMEM203 mRNA levels are associated with disease activ-
ity, as assessed by serum levels of the complement protein C3. Iden-
tification of TMEM203 sheds light into the control of STING-mediated
innate immune responses, providing a potential novel mechanism for
therapeutic interventions in STING-associated inflammatory diseases.
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Innate immune sensing of microbial infections involves patho-gen pattern recognition receptors (PRRs), such as Toll-like
receptors (TLRs). Many TLR-dependent and -independent in-
nate signaling systems, including NOD-like receptors and sys-
tems recognizing intracellular DNA (1, 2), activate the TBK1/
IRF3 axis, a pathway of fundamental importance in immune
defense in both bacterial and viral diseases (3). Activation of this
pathway, which is of great phylogenetic antiquity (4), results in
the production of IFN-β, a cytokine critical for host defense
against both viruses and bacteria. As increasing evidence links
the PRR/TBK1/IRF3 axis to autoimmune disease (including
systemic lupus erythematosus [SLE]) (5), vaccine responses (6), and
the development of malignancy (7), the identification of regulators
of this pathway may reveal novel therapeutic targets.
One important component mediating activation of the TBK1/
IRF3 pathway is the endosomal multitransmembrane protein
STimulator of IFN Genes (STING) (2, 8). STING is activated by
the double-stranded DNA (dsDNA) sensor IFI16, or by direct
binding to bacteria-secreted cyclic dinucleotide c-di-AMP, c-
di-GMP, and 3′3′-cGAMP, as well as cGAS-catalyzed (9, 10)
mammalian ligand 2′3′-cGAMP. Its critical role is proven both
by the lack of IFN induction following viral, bacterial, or syn-
thetic DNA stimulation in STING-deficient cells (2, 11), and by
the increased sensitivity of STING-deficient mice to DNA viru-
ses such as HSV-1 (2). Constitutively activated STING variants
have been found in patients diagnosed with severe symptoms of
type I interferonopathy, leading to diseases such as STING-
associated vasculopathy with onset in infancy (SAVI) (12), sys-
temic lupus erythematosus (SLE) (5), and familial chilblain lupus
(FCL) (13). The importance of STING activity in health and
disease has also been the subject of recent reviews (14).
Following STING activation, the serine/threonine kinase TBK1
is recruited to the cytosolic face of the endo-lysosome/endoplasmic
reticulum (ER) (15). At these intracellular vesicles, STING is
targeted for a regulatory (K27-linked) ubiquitination by the E3
ubiquitin ligase autocrine motility factor receptor (AMFR), trig-
gering its activation and the subsequent phosphorylation of the
transcription factor IRF3 (16). Once phosphorylated, IRF3 di-
merizes and translocates to the nucleus where it drives the ex-
pression of genes containing IRF binding sites in their promoter,
predominantly the type I interferons IFN-α and IFN-β (15).
Postactivation, STING is sorted to the endo-lysosomes where it is
targeted by microtubule-associated proteins 1A/1B light chain 3B
(LC3) and autophagy-related protein 9a (Atg9a) to attenuate its
functions (17, 18). Recent work identified the Ca2+ sensor STIM1
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as a critical STING binding partner, responsible for its retention
in the ER, thus preventing spontaneous activation (19). However,
little is known about the mechanisms and interacting proteins that
drive STING translocation to the endo-lysosomal compartment.
While most studies have described STING as a critical com-
ponent in cytosolic nucleic acid recognition, STING has also
been shown to play a role in augmented IRF3 activation and type
I IFN (IFN-I) induction upon concomitant ER stress and LPS
stimulation (2) via late-TLR4 signaling (20). Despite the fun-
damental importance of STING in both antibacterial and anti-
viral immunity, its partners remain largely unknown, with many
aspects of its mechanism of action still being poorly understood.
In previous functional screens discovering novel regulators of
inflammation (21), we reported the identification of TMEM203 as
a previously unknown proinflammatory gene in mouse macro-
phages (21). Here, we demonstrate that TMEM203, a protein that
was recently shown to be endosomal and interacts with the pleio-
tropic inositol phosphate signaling pathway protein IP3R (22), is
associated with SLE disease activity, forms a functional and ligand-
dependent complex with STING, and promotes its translocation to
endo-lysosomes. TMEM203 is a regulator of signaling pathways
activated in response to diverse bacterial and viral stimuli, in-
cluding cyclic dinucleotides, and can serve as a future therapeutic
target to attenuate STING-mediated pathological IFN activation.
Results
TMEM203 Is an Evolutionarily Conserved Putative Transmembrane
Protein, Regulated by Inflammatory Stimuli. We have previously
identified multiple regulators of inflammatory signaling in
macrophages by genome-wide expression screening for genes
which drove expression of the inflammatory chemokine Cxcl2
when transfected into RAW 264.7 cells (21); TMEM203 was
one such protein. Multiple alignment of TMEM203 orthologs
from a wide range of species demonstrated that TMEM203 is
an evolutionally highly conserved gene (SI Appendix, Fig. S1),
encoding a 136-amino acid protein, with the mouse and human
orthologs being 98% identical. Interestingly, a survey of the
GenBank database revealed that only a single copy of this gene
is present in both invertebrate and vertebrate species; TMPred
(23) predicts four putative membrane-spanning helices (SI
Appendix, Fig. S1).
Dysregulated expression of key innate immune signaling
molecules has previously been linked to the development of human
pathologies, including systemic lupus erythematous (SLE), an in-
flammatory disease often characterized by both the recruitment of
immune cells, including T lymphocytes, and their excessive type I
IFN production in the affected tissues. Thus, we have analyzed the
mRNA levels of two well-characterized intracellular signaling reg-
ulators, mitochondrial antiviral signaling protein (MAVS) and
STING, as well as TMEM203, in T cells isolated from the blood of
recently diagnosed, treatment-naive SLE patients. Both MAVS and
STING have previously been implicated in driving IFN production
in SLE (24, 25). We found significantly reduced, almost abolished,
MAVS expression, with marked up-regulation of TMEM203 (mean
13.8 ± SD 6.5-fold induction, lower:upper interquartile = 8.6:18.8)
(Fig. 1A). Further, TMEM203 mRNA levels in T cells from
treatment-naive SLE patients inversely correlated with the plasma
levels of complement factor C3 (Fig. 1B), a clinically used marker
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Fig. 1. (A and B) TMEM203 mRNA level is elevated in a cohort of SLE patients. (A) MAVS, TMEM203, and STING mRNA levels in PHA-L–activated T cells were
assessed by RT-qPCR from a cohort of treatment-naive systemic erythematous lupus (SLE) patients and in healthy individuals. (B) Spearman correlation co-
efficient of C3 complement plasma level was assessed against fold TMEM203 mRNA induction in SLE patients (95% CI: dashed lines). (C) Overexpression of
Tmem203 augments LPS-induced Cxcl2 activation. RAW 264.7 cells were transfected with the Cxcl2-pLuc and EF1-rLuc reporters, and with Tmem203 ex-
pression plasmid (dashed line) or empty control vector (solid line). Cells were stimulated with the stated concentration of LPS for 6 h. Two-way ANOVA with
Sidak correction, n = 3. (D) Knockdown of Tmem203 impairs LPS-induced Cxcl2 activation. RAW 264.7 cells were transfected with the Cxcl2-pLuc and EF1-rLuc
reporters, and with siRNA against Tmem203 (dashed line) or nontargeting si-scrambled (solid line). Cells were stimulated with the stated concentration of LPS
for 6 h. Two-way ANOVAwith Sidak correction, n = 3. (E) Dominant negative (DN) signaling molecules fail to inhibit Tmem203 induced Cxcl2 promoter activity. RAW
264.7 cells were transfected as in F, and the ability of the DN constructs to block overexpressed Tmem203-induced Cxcl2 activation was tested, n = 2. (F)
Tmem203 induces Cxcl2 promoter via the Sting/Tbk1/Irf3 pathway. RAW 264.7 cells were transfected with the Cxcl2-pLuc, TK-rLuc reporters, and Tmem203 expression
plasmid, together with siRNA as indicated. One-way ANOVA, n = 3. PHA-L: Phytohaemagglutinin-L. *P < 0.05, **P < 0.01, ****P < 0.0001; ns: not significant.
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of activated innate immunity. A pilot analysis of MAVS protein
levels in T cells isolated from SLE versus healthy control subjects
has also shown a trend toward reduced MAVS expression in SLE
(SI Appendix, Fig. S2A). Taken together, our data suggest that
TMEM203 may play a role in the development of this disease and
that this activity might be coupled to excessive production of type
I IFN.
A search in the transcriptome database thebiogps.org (26)
indicated that TMEM203 is highly expressed in myeloid cells,
including macrophages, in addition to T cells. Since our ex-
pression screen showed that TMEM203 may act as a signaling
regulator in myeloid cells (21), we first tested how chemokine
expression in murine macrophages is controlled by TMEM203.
Compared with controls, Cxcl2 promoter activity in LPS-
stimulated RAW 264.7 cells was enhanced by the over-
expression of Tmem203 (Fig. 1C), while being impaired by the
siRNA-mediated down-regulation of Tmem203 (Fig. 1D), sug-
gesting that TMEM203 is likely to act downstream of Toll-like
receptors (TLRs) and/or other innate immune sensors.
We next characterized the molecular pathways for Tmem203
action, using Cxcl2 promoter activity as a surrogate of the acti-
vation of canonical TLR pathways (27). While LPS-induced ac-
tivation of a Cxcl2-luciferase reporter in RAW 264.7 cells was
blocked (SI Appendix, Fig. S2B), the Tmem203-induced Cxcl2
activation (∼3-fold above baseline) was not inhibited by the ex-
pression of the dominant negative forms of signaling mediators
of canonical LPS signaling: Irak1, Trif, MyD88, Tram, Mal, and
Traf6 (Fig. 1E). Similarly, pharmacological inhibitors of mitogen-
activated protein kinase (MAPK) impaired LPS-, but not over-
expressed Tmem203-induced, Cxcl2 promoter activities (SI Ap-
pendix, Fig. S2C). Therefore, we concluded that, while TMEM203
is a proinflammatory mediator/effector, it is likely to act in-
dependently from the canonical TLR and MAPK networks. We
therefore explored whether TMEM203 acts on the noncanonical
inflammatory pathway since LPS also induces the TRIF-TRAM/
TBK1/IRF3 signaling axis via endosomal “late signaling,” leading
to activation of multiple inflammatory cytokines, including inter-
ferons (28). The TBK1/IRF3 axis is known to couple to the pro-
tein STING, a critical regulator of cytosolic double-stranded DNA
detection (29, 30), and whose activities are mostly independent of
MAPK and canonical TLR mediators (15, 30, 31). Activation of
STING induces TBK1 phosphorylation (15), which subsequently
induces IRF3 or NF-κB to elicit the type I IFN response and a
variety of proinflammatory cytokines, including TNF, IL-6, and
several chemokines (15).
Since Shambharkar et al. (22) have previously reported that
TMEM203 is localized on ER membranes and that our above
data suggested that TMEM203 is closely related to chemokine
expression and SLE disease indications, we hypothesized that
TMEM203 may regulate STING-mediated signaling events.
Therefore, a Tmem203 overexpressing plasmid construct and
siRNA against the STING-signaling effectors Tbk1 and Irf3 were
cotransfected into RAW 264.7 cells, followed by the measure-
ment of Cxcl2 promoter activities. As Tmem203 overexpression
resulted in elevated Cxcl2 activity and the simultaneous suppression
of Sting or its downstream regulators significantly reduced it (Fig.
1F), we concluded that TMEM203 potentially acts upstream or in
parallel to a STING-dependent signaling pathway.
TMEM203 Interacts with STING and Competes for STING Binding with
STIM1. To establish whether TMEM203 coregulates STING,
Tmem203 expression levels were examined first in mouse bone
marrow-derived macrophages (isolated from C57/BL6 mice) after
stimulation with LPS, endogenous STING ligand 2′3′-cGAMP
(29), or microbial secreted STING ligand 3′3′-cGAMP (32). Each
tested stimulus rapidly induced Tmem203 mRNA levels, albeit with
different kinetics (Fig. 2 A–C).
Based on our observation that suppression of STING ex-
pression impaired TMEM203-induced Cxcl2 activation (Fig. 1F)
and that STING and TMEM203 are both localized in in-
tracellular membranes (22, 33), we questioned whether STING
and TMEM203 directly interact and coregulate the activation of
an inflammatory response. Coimmunoprecipitation of Myc-Sting
and Flag-Tmem203 in HEK293T cells (Fig. 2D) confirmed that a
molecular complex is formed between these two proteins. To
further validate the association of TMEM203 and STING, we
used the Yellow Fluorescence Protein (YFP) (Venus derivative)
fragment complementation assay (PCA), which is based on
expressing each putative binding partner in fusion with either the
N-terminal (V1) or C-terminal (V2) portion of YFP (34, 35)
(Fig. 2E). When the two test proteins interact, the YFP fluo-
rophore self-assembles in a cyclization reaction which is essen-
tially irreversible (36). This stable fluorescent signal can be
detected by flow cytometry or fluorescence microscopy. We used
this technique to ask whether TMEM203 and STING can in-
teract intracellularly (Fig. 2E) and observed a punctate mem-
brane/vesicular distribution of fluorescence labeling the
TMEM203/STING complex (Fig. 2F). Interestingly, a similar
distribution of TMEM203 dimer (or higher order multimer) was
also observed (Fig. 2G). As TMEM203 and STING are each
predicted to contain four transmembrane domains, the posi-
tioning of the V1 or V2 PCA tags enabled us to map the relative
orientation of the C and N termini of these proteins. In agree-
ment with the proposed schematic model in Fig. 2E, TMEM203
and STING with either N terminus and C terminus tags can lead
to the formation of a fluorescent complex (Fig. 2H, second and
third bar) while a strong signal was also seen by TMEM203 di-
merization (Fig. 2H, fourth bar). A further insight into molecular
mechanisms TMEM203/STING activity and their potential
common binding partners was gained by demonstrating that the
recently discovered STING-interacting protein STIM1 (19) also
interacts with TMEM203 (Fig. 2I) and that STIM1 was able to
disrupt the TMEM203/STING complex in a dose-dependent man-
ner (Fig. 2J), suggesting that STIM1 and TMEM203 may com-
pete for STING binding.
TMEM203 Down-Regulation Impairs cGAMP-Induced STING-Mediated
Type I IFN Expression. STING predominantly mediates type I IFN
activation in response to pathogen-associated cyclic-dinucleotide
production in the cytoplasm (29, 30, 37). Building on these
findings, we investigated the importance of TMEM203 in me-
diating STING activation in human monocyte-derived macro-
phages (MDMs). CD14-positive human monocytes (SI Appendix,
Fig. S3A) were isolated from whole blood and differentiated
into MDMs (SI Appendix, Fig. S3B) by macrophage colony-
stimulating factor. MDMs were transfected with control or
TMEM203 targeting siRNA, followed by a 3-h stimulation of
these cells with 2′3′-cGAMP or 3′3′-cGAMP, 48 h post-
transfection. RT-qPCR analysis of TMEM203 mRNA levels
confirmed a highly robust (>70%) knockdown in siTMEM203-
targeted MDMs (Fig. 3 A and B), which was accompanied by a
significant inhibition of cGAMP-induced IFN-I expression in
human MDM samples obtained from a cohort of healthy indi-
viduals (Fig. 3 C and D). While the amount of IFN-β mRNA
produced in these samples showed donor-specific variation upon
ligand stimulation (SI Appendix, Fig. S3 C and D), siTMEM203
treatment in each case reduced 2′3′-cGAMP and 3′3′-cGAMP
induced IFN-β mRNA levels by ∼50% (Fig. 3 C and D). In
contrast, levels of IL-8 chemokine mRNA were not induced
under both stimulation conditions (0- to 3-fold, depending on the
specific donor or MDM isolation) although its levels were also
reduced by TMEM203 suppression in response to 2′3′-cGAMP
treatment (Fig. 3C).
To expand on the above findings from primary human mac-
rophages, we investigated whether TMEM203 displays similar
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STING regulatory behavior in mouse macrophages. siRNA
knockdown of Tmem203 or Sting was performed in immortalized
bone marrow-derived macrophages (iBMDMs), followed by 3-h
stimulation with the physiological STING ligand 2′3′-cGAMP or
the synthetic ligand DMXAA, also known as Vadimesan (38),
that selectively targets the mouse but not the human protein.
Efficient suppression of both Tmem203 and Sting was confirmed
by RT-qPCR analysis (Fig. 3 E and F). Similar to MDMs, 2′3′-
cGAMP robustly induced IFN-I expression in iBMDMs (SI
Appendix, Fig. S3E), and this was impaired by Tmem203 or Sting
knockdown (Fig. 3G). However, IFN-I induction by DMXAA
was only reduced by the knockdown of Sting, but not Tmem203
(Fig. 3G), suggesting that Tmem203 regulation of Sting may be
ligand-dependent. To further test this, we used primary bone
marrow-derived macrophages (BMDMs) isolated from WT or
CRISPR-Cas9–targeted Tmem203 knockout (KO) mice (SI Ap-
pendix, Fig. S3F) and stimulated them with DMXAA or 2′3′-
cGAMP. In controls, both STING ligands induced a marked
Ifnb1 up-regulation (SI Appendix, Fig. S3G), but only 2′3′-
cGAMP and not DMXAA mediated Ifnb1 expression was re-
duced by Tmem203 deficiency (Fig. 3H). In HeLa cells, which
express lower levels of STING than the RAW 264.7 cells used in
our initial screening (21), overexpression of TMEM203 alone did
not elevate proinflammatory activities, as measured by the acti-
vation of a previously described (39) luciferase reporter, but it
augmented overexpressed STING-induced responses (Fig. 3I).
Constitutive overexpression of Tmem203 in RAW 264.7 cells (SI
Appendix, Fig. S4B) significantly potentiated STING ligand-
induced IFN activation (Fig. 3J). From the above data, we con-
clude that TMEM203 is a critical regulator of STING-induced
type I IFN production and that its suppression impedes this
process in response to specific STING ligands.
TMEM203 Levels Regulate TBK1/IRF3 Activation Downstream of
STING. To further characterize the functional contribution of
TMEM203 to cGAMP-induced STING-signaling events, activa-
tion of TBK1 and IRF3 was compared between control and
TMEM203-overexpressing or knockout RAW 264.7 cells. Each
of these signaling molecules has previously been shown to be
phosphorylated (and thus activated) in a STING-dependent
manner, including responses to cytosolic dsDNA sensing (15,
40). While CRISPR/Cas9-mediated Tmem203 knockout in RAW
264.7 cells (SI Appendix, Fig. S4A) resulted in an impaired TBK1/
IRF3 phosphorylation (Fig. 4A), Tmem203 overexpression (SI
Appendix, Fig. S4B) augmented TBK1/IRF3 activation after 3′3′-
cGAMP stimulation (Fig. 4B). Similar TMEM203-dependent
changes were seen in these cells after human simplex virus-1
(HSV-1) infection (Fig. 4C), a dsDNA virus known to activate
the STING/TBK1/IRF3 signaling axis (41). Consistently, HSV-
1–stimulated IFNβ secretion was enhanced in Tmem203 over-
expressing cells (Fig. 4 D, Right) while it was impaired in Tmem203
knockout cells (Fig. 4 D, Left), confirming the functional signifi-
cance of Tmem203 in the regulation of STING-IFN signaling.
Finally, we analyzed IRF3 activation downstream of STING by
measuring the nuclear localization of IRF3 in control and
Tmem203-overexpressing macrophages. Activated STING in-
duces TBK1-IRF3 activation, leading to nuclear translocation of
IRF3 that is critical for the initiation of transcription of the type I
IFN genes (15). Elevated Tmem203 expression in RAW
264.7 cells indeed led to an enhanced, 3′3′-cGAMP–induced
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Fig. 2. TMEM203 interacts with STING and STIM1. (A–C) Tmem203 expression is transiently induced by inflammatory stimuli. Murine bone marrow-derived
macrophages were stimulated with LPS (A), 2′3′-cGAMP (B), or 3′3′-cGAMP (C) for the time indicated. The expression of Tmem203 was determined by RT-
qPCR, n = 2. (D) TMEM203 coprecipitates with STING. HEK293 T cells were transfected with either empty vector, FLAG-TMEM203, or Myc-STING. TMEM203-
containing complexes were immunoprecipitated (IP) using anti-FLAG–coated beads and blotted for Myc and FLAG, as indicated. Lysates were also immu-
noblotted for Myc and FLAG. n = 2. (E) Illustration of TMEM203-STING interaction by PCA. Tmem203 was tagged at its N terminus with the V1 fragment of
Venus yellow fluorescent protein while Sting was tagged at its N terminus with the V2 Venus fragment. Both Tmem203 and Sting proteins are predicted to
encode for four transmembrane domains (22, 54). Thus, this arrangement was predicted to localize the V1 and V2 tags to the same side of the lipid
membrane. (F and G). TMEM203 and its complex with STING are located in the cytoplasm, in perinuclear structures. HeLa cells were transfected with the
above-described Venus fusion protein expression plasmids. The “Venus” fluorescent signal, demonstrating TMEM203-STING interaction (F) or
TMEM203 dimerization (G), was visualized. (Magnification, 80×.) (Scale bar: 20 μm.) (H) TMEM203 forms dimers and interacts with STING in live cells. HEK293
T cells were cotransfected with the indicated fusion protein expression vectors; the Venus fluorescence signal was detected by flow cytometry. n = 4. (I)
TMEM203 coprecipitates with STIM1: HEK293 T cells were transfected with either empty vector, HA-TMEM203, or FLAG-STIM1. TMEM203-containing com-
plexes were immunoprecipitated (IP) using anti-FLAG–coated beads and blotted for HA and FLAG, as indicated. Lysates were also immunoblotted for HA and
FLAG. n = 2. (J) TMEM203 and STIM1 compete for binding to STING: TMEM203 and STING were tagged with the 1.1 and 2.1 fragment of Renilla luciferase,
respectively, to test for a molecular interaction between these proteins in live cells. Tmem203 and Sting fusion protein expression vectors, together with an
increasing dose of STIM1 expression vector, were transfected into HEK293 T cells. Relative luciferase activity was assessed 24 h posttransfection, n = 3.
IB: immunoblotting; MFI: mean fluorescence intensity.
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IRF3 nuclear localization (Fig. 4 E and F), in line with the time
frame observed for IRF phosphorylation (Fig. 4B).
Transmembrane Domains of STING Are Required for the Formation of
Its Complex with TMEM203. Having demonstrated the functional
significance of TMEM203-mediated regulation of STING, we
sought to further explore the mechanisms by which these two
proteins interact and investigate the underlying mechanisms of
selective, TMEM203-mediated regulation of STING activation.
Since TMEM203 regulates cGAMP-, but not DMXAA-induced
STING activation in macrophages, we proposed that these li-
gands may differentially influence the physical contact between
TMEM203 and STING. We established the Renilla fragment
protein complementation assay (Renilla PCA), which is based on
expressing Tmem203 or Sting in fusion with either the small part
(1.1) or the large part (2.1) of an engineered Renilla luciferase,
NanoBit (Fig. 5A). The association of TMEM203 and STING
causes a reversible assembly of a functional Renilla luciferase
enzyme, which then catalyzes the breakdown of luciferin. A ro-
bust interaction between TMEM203 and STING was observed
upon cotransfecting the Renilla PCA fusion constructs, and their
strong association was demonstrated by comparison with the
RelA–IκBα complex, which has been reported to form a stable
complex in resting cells (Fig. 5B). Next, we coexpressed 2.1N-
Sting and 1.1C-Tmem203 in HEK293T cells that were stimulated
with either 2′3′-cGAMP or DMXAA. We detected a rapid, time-
dependent reduction of the TMEM203–STING complex fol-
lowing cGAMP treatment, in contrast to an enhanced associa-
tion of these proteins upon DMXAA treatment (Fig. 5C). This
opposing effect of the two STING ligands on STING-
TMEM203 association is likely to underlie the differential reg-
ulation of STING signaling by TMEM203 as demonstrated in
BMDMs (Fig. 3 G and H).
TMEM203 is a 136-amino acid transmembrane protein with
no obvious regulatory domains at the exposed short cytoplasmic
regions. The protein sequence is highly conserved across verte-
brates, with only a 3-amino acid difference in the sequence be-
tween the human and the mouse genes (22) (SI Appendix, Fig.
S1). Thus, we speculated that the interaction between STING
and TMEM203 is likely to be coordinated by STING, which
contains complex regulatory domains. Although human and
mouse STING are only 81% similar in primary sequence and
68% similar in amino acid composition (10), functional domains
in STING are nonetheless spatially and structurally conserved
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Fig. 3. TMEM203 down-regulation impairs cGAMP-induced STING-mediated type I IFN expression. (A and B) Efficient TMEM203 knockdown in human
monocyte-derived macrophages (MDMs). MDMs were transiently transfected by scrambled control (siCtrl) or TMEM203 targeting siRNA. Posttransfection,
MDMs were left stimulated with ±4 μg/mL 2′3′-cGAMP (A) or 1 μg/mL 3′3′-cGAMP (B) for 3 h. TMEM203 knockdown was quantified by RT-qPCR. Multiple
Student’s t tests with Holm–Sidak corrections, n = 10 (A) and n = 4 (B). (C and D) TMEM203 knockdown impairs 2′3′-cGAMP (C) and 3′3′-cGAMP (D) induced
IFN-β production in MDMs. 2′3′-cGAMP (4 μg/mL) or 3′3′-cGAMP (1 μg/mL) stimulated (3 h) IFN-β production of siCtrl vs. siTMEM203-transfected MDMs from
four donors was compared by normalizing IFN-β levels of siTMEM203-treated cells to the siCtrl treatment for each individual. Student’s t test, n = 4. (E and F)
Efficient Tmem203 (E) and Sting (F) knockdown in immortalized mouse bone marrow-derived macrophages (iBMDMs). iBMDMs were transiently transfected
by scrambled control (siCtrl), Tmem203, or Sting targeting siRNA. Posttransfection, cells were left stimulated with ±25 μg/mL DMXAA or 20 μg/mL 2′3′-cGAMP
for 3 h. Tmem203 and Sting knockdown was quantified by RT-qPCR. Multiple Student’s t tests with Holm–Sidak corrections, n = 4. (G) 2′3′-cGAMP, but not
DMXAA, induced Ifnb1 expression is impaired by Tmem203 knockdown in iBMDMs. IFN-β induction by DMXAA (25 μg/mL) or 2′3′-cGAMP (20 μg/mL) stim-
ulation (3 h) in the siTmem203 or siSting transfected iBMDMs was compared with that in the siCtrl-treated cells. One-way ANOVA, n = 4. (H) 2′3′-cGAMP, but
not DMXAA, induced Ifnb1 expression is impaired by Tmem203 knockout in bone marrow-derived macrophages (BMDMs). BMDMs derived from WT or
Tmem203 knockout C57BL/6 mice were stimulated with DMXAA (50 μg/mL) or 2′3′-cGAMP (10 μg/mL) for 3 h before Ifnb1 expression levels were analyzed by
RT-qPCR. Multiple Student’s t tests with Holm–Sidak corrections, n = 6. (I) Tmem203 overexpression augments Sting-induced IL-8 activation. HEK293 T cells
were cotransfected with IFN-β reporter and plasmids expressing Sting, Tmem203, or controls. Data are expressed as fold change in reporter induction relative
to the control plasmid, with (gray bars) or without (black bars) stimulation of DMXAA (100 μg/mL, 6 h). Two-way ANOVA, n = 3. (J) Tmem203 overexpression
augments Ifnb activation in RAW 264.7 cells. Vector or Tmem203 overexpression (OE Tmem203) transfected RAW 264.7 cells were stimulated with 3′3′-cGAMP
for the time indicated. The expression of Ifnb was determined by quantitative RT-qPCR. Student’s t tests, n = 3. DMEM: Dulbecco’s Modified Eagle Medium;
DMSO: dimethyl sulfoxide. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns: not significant.
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across the two species. Previous studies on the structure of
STING have identified the C-terminal cytoplasmic domain as the
site for protein–protein interactions and ligand binding whereas
the N-terminal transmembrane (TM) domains are mainly
thought to be responsible for membrane anchorage (42). The
cytoplasmic region of STING (approximately amino acids 153 to
378 in mouse) comprises of three domains: the dimerization
domain (DD) (or helices α-5/α-6) formed by amino acids ∼155 to
180; the cyclic dinucleotide binding domain (CBD) formed by
amino acids ∼153 to 340; and the cytoplasmic-terminal tail domain
(CTT) formed by amino acids ∼340 to 378 (amino acids ∼340 to
379 in human) (4). The CTT is involved in TBK1/IRF3 binding
and activation and is essential for type I IFN induction (15). To
identify the molecular domains of STING required for its in-
teraction with TMEM203, we created mutant Sting constructs
that contain deletions of TM, CBD, or the CTT domain (Fig. 5D).
Coimmunoprecipitation of HA-tagged WT or mutant STING
with Flag-TMEM203 from HEK293 T lysates showed that the
STING–TMEM203 complex is formed in the presence of STING’s
TM domains (Fig. 5E, lanes 1 to 3 and 5) whereas the presence of
CBD alone led to a very weak STING–TMEM203 interaction (Fig.
5E, lanes 4 and 6).
To substantiate these findings, 141A, 184L, 243V, and 344A
Sting truncations were created (Fig. 5F), expressing TM domains
only (TM), TM and dimerization domain (TM+DD), a disrupted
cyclic dinucleotide binding domain (d-CBD), or CTT deleted
STING (ΔCTT), respectively. Both the mutant and WT Sting
were fused with the YFP expression plasmids, and their ex-
pression was tested by Western blot. Compared with the WT
Sting, TM and ΔCTT mutants (SI Appendix, Fig. S5 A and B,
lanes 3 and 6) showed enhanced protein expression whereas the
TM+DD and d-CBD mutants showed reduced expression (SI
Appendix, Fig. S5 A and B, lanes 4 and 5). Next, we fused the
mutants and WT Sting with the V1 fragment of the previously
described split YFP (Fig. 2E), which were cotransfected with the
complementary V2-tagged Tmem203 expression plasmid into
HEK293 T cells; the fluorescent signal was quantified by flow
cytometry (Fig. 5G). To ensure that the overexpression of
Tmem203 or Sting does not induce a nonspecific ER stress re-
sponse (43), the level of spliced XBP1 gene, the presence of
which is characteristic of a the unfolded protein response (44),
was assessed in HEK293T cells, transfected with pcDNA3.1(con-
trol) or Tmem203-Sting PCA constructs. No substantial increase of
XBP1 splicing was detected by RT-qPCR in Tmem203 and Sting
expressing cells (SI Appendix, Fig. S6 A–C). Compared with theWT
Tmem203–WT Sting interaction, a stronger protein interaction was
observed between Tmem203 and Sting TM, TM+DD, and ΔCTT,
respectively (Fig. 5G). However, d-CBD Sting showed an impaired
interaction with Tmem203, due to reduced protein expression
levels (SI Appendix, Fig. S5 A and B), potentially caused by deg-
radation of dysfunctional STING protein. Of note, while the en-
hanced interaction between TMEM203 and STING-TM mutant
was paralleled with high expression of this truncated STING pro-
tein, the TM+DD mutant exhibited similar association at a much
lower STING protein expression level (Fig. 5 F and G).
To complement the above mapping of critical STING residues
for the formation of TMEM203/STING complex, we generated
mutants expressing truncated forms of TMEM203 (Fig. 5H).
First, we verified that these mutants fused to EYFP are expressed
at similar levels to the full-length TMEM203 when transiently
transfected into HEK293T cells (SI Appendix, Fig. S5C). Next, we
used the Renilla PCA assay to map the interaction between trun-
cated TMEM203 mutants and STING. This analysis demonstrated
that the N-terminal 51 aa of TMEM203 are sufficient to mediate
the TMEM203/STING interaction (Fig. 5I).
In short, we conclude that interaction with TMEM203 is de-
pendent on the N-terminal transmembrane domains of both
STING and TMEM203 and that STING’s dimerization domain
is potentially a significant regulator of their interaction.
TMEM203 Localizes STING to Lysosomes. To further study the lo-
calization of TMEM203, HeLa cells were transiently transfected
with mCherry-Tmem203. TMEM203 was predominantly found
Fig. 4. TMEM203 levels regulate TBK1/IRF3 activation downstream of
STING. (A) CRISPR/Cas9-mediated Tmem203 knockout results in reduced
TBK1 and IRF3 phosphorylation upon STING stimulation. Vector or CRISPR/
Cas9-mediated Tmem203 knockout (KO Tmem203) RAW 264.7 cells were
stimulated with 3′3′-cGAMP (1 μg/mL) for the time indicated. Activation of
TBK1 and IRF3 was examined by Western blot analysis. Membranes were
blotted with anti-phospho-TBK1 (p-TBK1), anti-total TBK1 (t-TBK1), anti-
phospho-IRF3 (p-IRF3), and anti-total IRF3 (t-IRF3) as indicated (n = 3). (B)
Increased TBK1-IRF3 activation in Tmem203-overexpressing RAW 264.7 cells
in response to STING stimulation. Vector- or Tmem203-overexpressing (OE
Tmem203) RAW 264.7 cells were stimulated with 3′3′-cGAMP (1 μg/mL) for
the time indicated. Activation of TBK1 and IRF3 was examined by Western
blot analysis. Membranes were blotted with anti-phospho-TBK1 (p-TBK1),
anti-total TBK1 (t-TBK1), anti-phospho-IRF3 (p-IRF3), and anti-total IRF3
(t-IRF3) as indicated (n = 3). (C) Increased TBK1-IRF3 activation in Tmem203-
overexpressing RAW 264.7 cells in response to HSV infection. Vector- or
Tmem203-overexpressing RAW 264.7 cells were infected with HSV-1 for the
time indicated. Activation of TBK1 and IRF3 was examined by Western blot
analysis. Membranes were blotted with anti-phospho-TBK1 (p-TBK1), anti-
total TBK1 (t-TBK1), anti-phospho-IRF3 (p-IRF3), and anti-total IRF3 (t-IRF3)
as indicated (n = 3). (D) IFNβ cytokine secretion is impaired in Tmem203
knockout RAW 264.7 cells (Left) and is enhanced in Tmem203-overexpressing
cells (Right) in response to HSV infection. CRISPR/Cas9-mediated Tmem203
knockout (or Vector) and Tmem203-overexpressing (or Vector) RAW 264.7 cells
were infected with HSV-1 for 6 h, and Ifnb1 secretion was measured by ELISA.
n = 3. (E and F) Tmem203 overexpression enhances IRF3 nuclear accumulation
in macrophages in response to STING stimulation. Vector- and Tmem203-
overexpressing RAW 264.7 cells were stimulated with 1 μg/mL 3′3′-cGAMP for
6 h. Subcellular localization of IRF3 was determined by IRF3 intracellular
staining, and confocal fluorescence images were captured (F) (Scale bar: 10 μm).
Average IRF3 nuclear fluorescence intensity of 50 to 200 cells was quantified
using ImageJ (F). n = 3. *P < 0.05, **P < 0.01, ***P < 0.001.
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in perinuclear membrane structures in accordance with a pre-
vious report of ER localization (Fig. 6A) (22). Stimulation with
LPS led to TMEM203 translocation to perinuclear, punctate mem-
branes or vesicles (Fig. 6A). A more detailed analysis revealed a
transient colocalization between TMEM203 and the lysosomal
marker LAMP1 at 30 min stimulation with LPS in HeLa cells
(Fig. 6 B and C and SI Appendix, Fig. S7). This rapid ER-to-vesicle
translocation of TMEM203 correlates with the kinetics of trans-
location seen for STING during activation (45). When activated,
STING has been shown to traffic to endo-lysosomal structures,
termed Endoplasmic Reticulum Golgi Intermediate Compartments
(46). Thus, we probed whether TMEM203 is expressed in this
compartment and showed colocalization with the protein ERGIC-
53 in RAW264.7 cells, stably expressing GFP-TMEM203 (Fig. 6D).
Coexpression of GFP-STING and mCherry-TMEM203 also
revealed a significant colocalization of these proteins (Fig. 6E). To
characterize the localization of the TMEM203–STING complex, we
cotransfected the previously described Venus PCA constructs of
these two proteins (Fig. 2E) into HeLa cells and costained with ei-
ther cell-permeable, lysosome- or ER-specific fluorescent dyes. The
STING-TMEM203 complex was mainly expressed on lysosomal
membranes rather than the ER (Fig. 6 F–I and SI Appendix, Fig.
S8), a distribution consistent with the previously described localiza-
tion pattern of activated STING (33). We therefore speculated that
coexpression of TMEM203 and STING may preactivate or sensitize
the STING pathway, thus leading to a lysosomal translocation, even
in the absence of ligands. Finally, the impact of TMEM203 in
cGAMP-induced STING trafficking was addressed in TMEM203−/−
BMDMs where we showed that STING is retained in the ER even
after 3 h of 3′3′cGAMP stimulation (Fig. 6J and SI Appendix, Fig.
S9). Thus, we concluded that TMEM203 expression is required for
STING trafficking to lysosomes.
Using mutants expressing their C-terminal domains required for
association in the YFP-PCA system, we tested the cellular distri-
bution of the STING/TMEM203 complex. The TM-STING and
wild-type TMEM203 complex showed a more equal localization
between the ER and lysosomes (Fig. 7 A–C and SI Appendix, Fig.
S10), compared with the WT-TMEM203/WT-STING complex (Fig.
6 F–I), likely due to the loss of STING’s regulatory site for post-
translational modification required to direct its trafficking. However,
there was still a significant enrichment of this complex in the lyso-
somal compartment (Fig. 7C). In contrast, the complex between the
N-terminal domain of TMEM203 (TMEM203 V51X) and WT-
STING was no longer preferentially localized to lysosomes (Fig. 7
Fig. 5. Molecular determinants of TMEM203-STING complex formation. (A) Detection of TMEM203-STING interaction by Renilla PCA. Tmem203 was tagged
at its C terminus with the 1.1 (small) fragment of Renilla luciferase reporter while Sting was tagged at its N terminus with the 2.1 (large) Renilla fragment. (B)
TMEM203 and STING interact in live cells. HEK293 T cells were cotransfected with the indicated fusion protein expression vectors; Renilla luciferase signal was
detected by Nano-Glo live cell luciferase assay. Relative luminescence intensity was plotted compared with the negative control transfection of Nano-BIT
construct. n = 3. (C) TMEM203-STING interaction is differentially regulated by DMXAA and 2′3′-cGAMP. TMEM203 and STING were tagged at their N termini
with the 1.1 and 2.1 fragment of Renilla luciferase, respectively, to test for a molecular interaction between these proteins in live cells. Tmem203 and Sting
were transfected into HEK293 T cells for 24 h and were then stimulated with DMXAA (50 μg/mL) and 2′3′-cGAMP (10 μg/mL) for the indicated time. Luciferase
activity was calculated relative to Hoechst fluorescence (cell numbers) and calculated relative to the 2.5-min time point. n = 4. (D and E)
TMEM203 coprecipitates with the STING N-terminal transmembrane region. WT and five mutant Sting constructs were created as indicated and fused with HA
tags. CBD, CBD domain of Sting; ΔCBD, Sting without cyclic-dinucleotide binding domain (CBD); ΔCTT, Sting without cytoplasmic tail; ΔTM, Sting without
transmembrane domain; TM, transmembrane domain. (E) HEK293 T cells were transfected with either empty vector, Flag-Tmem203, or HA-Sting (WT/mu-
tants). Tmem203-containing complexes were immunoprecipitated (IP) using anti-Flag–coated beads and blotted for Flag and HA, as indicated. Lysates were
also immunoblotted (IB) for Flag and HA. n = 2. (F) STING truncation mutants. Four serial truncation Sting mutants were individually created: after its N-
terminal transmembrane domains (TM); after the dimerization domain (TM+DD); inside the cyclic dinucleotide binding domain (d-CBD); and before the C-
terminal cytoplasmic terminal tail (ΔCTT). (G) TMEM203-STING association is not eliminated by C-terminal truncations of STING. HEK293 T cells were
cotransfected with the Tmem203 and Sting WT/mutants cloned into the Venus vector system as described in Fig. 2E; Venus fluorescence signal was detected
by flow cytometry. Relative mean fluorescence intensity was plotted compared with the STINGWT–TMEM203 interaction. n = 4 to 7. (H) TMEM203 truncation
mutants. Three mutants, expressing truncated versions of TMEM203 have been generated, as indicated. (I) AA1-51 of TMEM203 are sufficient to interact with
STING. HEK293 T cells were cotransfected with the Tmem203 WT/mutants and Sting cloned into the Renilla reporter system as described in Fig. 5A. Renilla
activity was measured 24 h posttransfection, and relative luciferase activity was calculated relative to Hoechst fluorescence (cell numbers). n = 3. **P < 0.01,
****P < 0.0001.
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D–F), suggesting that residues 52 to 136 of TMEM203 are critical
for driving the STING/TMEM203 complex to this compartment.
Discussion
In this study, we show that an inflammatory regulator, TMEM203,
forms part of a functional signaling complex with STING, thus
regulating the activity of the effector kinase TBK1 and the tran-
scription factor IRF3, leading to activation of type I IFN ex-
pression. TMEM203 acts independently of the canonical PRR
systems, and the STING/TMEM203 complex localizes mainly
in lysosomes. Our experiments aiming to further dissect the
underlying molecular mechanisms in human and mouse macro-
phages revealed that TMEM203 regulates STING in a ligand-
dependent manner. Upon STING activation by cyclic dinucleo-
tides and HSV-1 but not by DMXAA, TMEM203 promotes the
activation of TBK1 and IRF3. Finally, our data using truncated
forms of STING and TMEM203 reveal that their N-terminal
transmembrane domains are sufficient to form a complex and
that this interaction is regulated by the α-helix/dimerization
domain on STING. These experiments also confirm that the C-
terminal region of TMEM203 is responsible for lysosomal
trafficking of the TMEM203/STING complex. Supported by the
mechanistic studies presented here, we propose a model (Fig.
7G) by which TMEM203-STING acts and promotes the TBK1-
IRF3-IFN activation.
While detailed structural studies will be required to shed light
on the exact molecular mechanisms by which TMEM203 regu-
lates STING activity, our data demonstrate the important role
for TMEM203 in ligand-dependent STING activation. In three
primary and established macrophage systems, immunostimulation
by cGAMP was impeded by the reduction/loss of TMEM203
while DMXAA-induced IFN-β expression only changed in par-
allel to Sting but not Tmem203 RNA levels. The mouse-specific
ligand DMXAA binds to STING via mechanisms similar to
cGAMP, but different amino acids are involved. Point mutations
of hSTING S162A and E260I render it sensitive to DMXAA
(47). Upon ligand binding, the STING dimer switches from an
open-inactive to a closed-active conformation, the binding
pocket being much tighter in the presence of 2′3′-cGAMP versus
DMXAA (47). This model is further supported by our finding
that DMXAA strengthens TMEM203-STING association while
cGAMP weakens it.
Our data also highlight the role for TMEM203 in directing
STING between intracellular compartments. While TMEM203
overexpression alone did not strongly enhance type I IFN ex-
pression in the mechanistic studies presented here, it has nev-
ertheless promoted vesicular translocation of STING and its
ER Lysosome
0%
20%
40%
60%
80%
100%
%
 o
ve
rla
y 
St
in
g 
W
T 
- T
m
em
20
3
****
ER Lysosome
0.0
0.2
0.4
0.6
0.8
1.0
M
O
C
.
St
in
g 
W
T 
- T
m
em
20
3 ****
A
B
F
G
H
Transmission
Sting - 
Tmem203 Overlay Zoom-In
Zoom-In
D
C
ITransmission
Sting - 
Tmem203 ER Overlay Zoom-In
Lysosome
E
J
DAPI LAMP1 Tmem203 Overlay Zoom-in
LPS
0 min
LPS
30 min
LPS
60 min 
OverlayERGIC
GFP-
Tmem203
Zoom-InOverlayGFP-Sting
Tmem203
-mCherryTransmission
0 30 60
0.0
0.2
0.4
0.6
0.8
LPS  (mins)
M
O
C
* *
0 5 15 30 60
LPS stimulation (mins)
Fig. 6. TMEM203 localizes STING to lysosomes. (A) LPS-induced perinuclear translocation of TMEM203. HeLa cells were transfected with TMEM203-mCherry
fusion protein expression plasmid and stimulated with 1 μg/mL LPS for the stated length of time. (B and C). TMEM203 transiently colocalizes with LAMP1 in
LPS-induced cells. HeLa cells were transfected with TMEM203-mCherry fusion protein expression plasmid and stimulated with 1 μg/mL LPS for the time in-
dicated. LAMP1 localization was visualized using Alexa Fluor 488-conjugated anti-mouse secondary antibody. (Magnification: 63×.) Manders’ Overlap Co-
efficient (MOC) was calculated using ImageJ. Two-way ANOVA. (D) TMEM203 colocalizes with ERGIC. RAW 264.7 cells stably expressing GFP-TMEM203 were
stained with anti-ERGIC-53/p58 (Sigma Aldrich), and confocal fluorescence images were captured. (E) TMEM203 colocalizes with STING. HeLa cells were
cotransfected with Sting-GFP and mCherry-Tmem203 expression plasmids, and their localization was visualized by confocal microscopy. (F–I) Coexpressed STING–
TMEM203 preferentially localizes to lysosomes. HeLa cells were cotransfected with the V1_Sting WT and V2_Tmem203 WT before ER (F) or lysosome (G)
staining; fluorescence signal was detected with confocal microscopy at 80×. (H) Overlay of Tmem203-Sting signals and organelle signals were quantified with
Fiji, and colocalization was calculated as the percentage of organelle with positive Tmem203-Sting detection. (I) Manders’ Overlap Coefficient (MOC) was
calculated using ImageJ. Student’s t test. (J) STING fails to translocate from the ER in Tmem203 knockout BMDMs. BMDMs derived from WT or
Tmem203 knockout C57BL/6 mice (n = 2 per genotype) were stimulated with 3′3′-cGAMP (10 μg/mL) for 3 h, and the overlap in STING localization (green) with
ER (red) was visualized by confocal microscopy. Representative images are shown. *P < 0.05, ****P < 0.0001. (Scale bars: A and B, 10 μm; E–G, 20 μm.)
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downstream IFN-β transcriptional activities. Recent literature
suggests that the N terminus of STING is indispensable for its
translocation from the ER to other membranes during stimula-
tion (42). Thus, the association of this domain with TMEM203
may provide a mechanistic explanation for the importance of this
STING domain. A recent study from Srikanth et al. reported that a
calcium sensor STIM1 is critical for the retention of STING at the
ER (19). Our finding that TMEM203 and STIM1 interact with each
other and that they also compete for binding with STING suggests
that these two proteins may together coordinate STING trafficking
between intracellular membrane compartments, thus providing a
critical control mechanism to prevent excessive IFN activation.
Host innate immunity is governed by a complex network of
proteins cooperating in response to a variety of pathogens and
autoimmune stimuli. Apart from the four well-established PRR
systems controlled by TLRs, C-type lectin receptors, NOD-like
receptors, and RIG-I–like receptors, innate immune signaling
also utilizes a range of accessory/adaptor proteins to maintain
the homeostasis of inflammation. STING is one of the major in-
tracellular sensors of cytoplasmic double-stranded DNA and is a
critical switch in the initiation of type I IFN production. A recent
report suggested that cGAMP-induced STING activity enhances
expression of inflammasome genes, thus providing a priming sig-
nal for activation of the NLRP3 inflammasome and the pro-
duction of IL1β (48). However, RAW264.7 cells have been shown
to harbor an inactivating mutation in the ASC1 adaptor protein
that renders the caspase-1 inflammasome inactive in these cells
(49). As TMEM203 is able to activate inflammatory signaling in
RAW264.7 cells, we speculate that this protein is therefore un-
likely to be involved in STING-mediated NLRP3 activation.
Recent work in mouse models of SLE has demonstrated that
STING is required for homeostatic expression of negative reg-
ulators of immune activation (5) while analysis of human mono-
cytes from SLE patients revealed a hyperactive STING signaling
that is regulated by the IFN-induced gene, IFIT3 (24). Analysis of
T cells (a critical source of type I IFN in this disease) (50, 51) from
a cohort of SLE-positive, treatment-naive patients revealed un-
altered STING and an elevated level of TMEM203, with a con-
current suppression of MAVS mRNA levels, suggesting that
TMEM203 may be an important and previously unrecognized
component in the pathology of SLE.
The physiological significance of STING has been demonstrated
during infection with HSV, adenovirus (ADV), human papilloma-
virus (HPV), and negative-stranded RNA viruses, such as vesicular
stomatitis virus (VSV) (2, 52). Gain-of-function STING variants
lead to autoimmune, inflammatory diseases such as SAVI and FCL,
manifesting clinically with symptoms of type I interferonopathy (12,
13). STING-mediated signaling is known to involve TBK1/IRF3 and
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Fig. 7. The C-terminal region (TM2-4) of TMEM203 is required for preferential localization of the STING–TMEM203 complex to lysosomes. (A–C) Localization
of TM-STING/WT-TMEM203 complex. HeLa cells were cotransfected with the V1_TM-Sting and V2_WT-Tmem203 before ER (A) or lysosome (B) staining;
fluorescence signal was detected under confocal microscopy at 80×. (C) Overlay of Tmem203-Sting signals and organelle signals was quantified with Fiji, and
colocalization was calculated as the percentage of organelle with positive Tmem203-Sting detection. Manders’ Overlap Coefficient (MOC) was calculated as
above. Student’s t test. (Scale bar: 20 μm.) (D–F) Localization of WT-STING/TMEM203-V51X. HeLa cells were cotransfected with the V1_WT-Sting and V2_V51X-
Tmem203 before ER (D) or lysosome (E) staining; fluorescence signal was detected under confocal microscopy at 80×. (F) Overlay of Tmem203-Sting signals
and organelle signals was quantified with Fiji, and colocalization was calculated as the percentage of organelle with positive Tmem203-Sting detection.
Manders’ Overlap Coefficient (MOC) was calculated as above. Student’s t test. (Scale bar: 20 μm.) (G) Proposed molecular model for TMEM203 action. In the
absence of immune stimuli, the type I IFN promoter has no transcriptional activity. Pathogen-released 3′3′-cGAMP or cGAS-produced 2′3′-cGAMP can induce
the canonical STING pathway, resulting in TBK1-IRF3 interaction and subsequent type I IFN expression. Internalized LPS-bound TLR4 activates the “late
signaling” events, which induce TMEM203-STIM1-STING interaction in the ER, leading to STING-TBK1-IRF3 activation and type I IFN expression. CDN,
cyclic dinucleotide; cGAMP, cGMP-AMP; cGAS, cGMP-AMP synthase; ER, endoplasmic reticulum; IRF3, IFN regulatory factor 3; LPS, lipopolysaccharide;
STIM1, Stromal Interaction Molecule 1; STING, Stimulator of IFN Genes; TBK1, TANK binding kinase; TLR4, Toll-like receptor 4; TMEM203, transmembrane
protein 203. ****P < 0.0001; NS: not significant.
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NF-κB; targeting STING activity for therapeutic purposes none-
theless thus far focused on inhibiting downstream IFN receptors,
and JAK/STAT (12, 13). Several cancer adjuvants showed promis-
ing antitumor effects in early clinical trials, but none has yet pro-
gressed to the clinic (53). Therefore, revealing TMEM203 as a
STING-centered signaling regulator is of significant interest to both
basic research to the understanding of diseases of IFN dysregulation
and to the development of therapeutics and adjuvants modifying
IFN induction.
Materials and Methods
Study Ethics. All human tissue samples were collected and used under pro-
tocols approved by the University of Szeged Review Board (Ref. No. 2833/
2011) and conformed to the declaration of Helsinki (1964 World Medical
Association Declaration of Helsinki). Human blood was taken and used under
protocols approved by the University of Sheffield Research Ethics Committee
(UREC) (Ref. SMBRER310). All participants gave written informed consent.
Plasmid constructs were generated using standard techniques or described
previously. For details, see SI Appendix. Primary cell isolation, culture, and
manipulation followed standard protocols, as described in SI Appendix.
Details of immunostaining and biochemical analyses are in the corre-
sponding figure legends and in SI Appendix.
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